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Genetic variants in the PPARD-PPARGC1A-NRF-TFAM mitochondriogenesispathway are neither associated with muscle characteristics nor physical performance in elderly 
Variaciones genéticas en la vía de la mitocondriogénesis PPARD-PPARGC1A-NRF-TFAM no están asociadas ni con características musculares ni con rendimiento físico en personas mayores
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We studied the influence of genetic polymorphisms involved in the PPARD-PPARGC1A-NRF-TFAM
mitochondriogenesis pathway (rs6949152, rs12594956, rs2267668, rs8192678, and rs1937) on muscle
phenotypes (thigh muscles’ cross-sectional, maximal handgrip-strength and 30-second chair stand-test)
and Barthel index in Caucasian (Spanish) community-dwelling old people (n=75, 21 men, 54 women;
71–94 years). We found no significant genetic associations with the studied phenotypes. Multiple, com-
plex gene-environment and gene-gene interactions which are yet to be determined are likely to play a
more determinant role. 
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Se estudió la influencia de los polimorfismos genéticos implicados en la vía de mitocondriogénesis
PPARD-PPARGC1A-NRF-TFAM (rs6949152, rs12594956, rs2267668, rs8192678 y rs1937) en distintos
fenotipos musculares (sección transversal muscular del muslo, fuerza máxima de prensión manual y 30
segundos de sentarse-levantarse de una silla) y en el índice de Barthel en personas mayores caucási-
cas (españoles) (n = 75, 21 hombres, 54 mujeres; 71 a 94 años). No se encontraron asociaciones gené-
ticas significativas con los fenotipos estudiados. Interacciones múltiples, complejos gen-ambiente y rela-
ciones gen-gen aún no determinadas podrían desempeñar un papel más determinante.
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Introduction 
estern populations are ageing. As more individuals live longer, we should try to 
elucidate the mechanisms involved in healthy ageing and preserving functional 
independence in later life. With regards to this, mitochondria are one of the most important 
organelles for understanding the ageing process (Vina, Gomez-Cabrera, Borras, Froio, 
Sanchis-Gomar, Martinez-Bello, & Pallardo, 2009b). A constant renewal of these organelles 
is crucial for maintaining their normal function. Yet the capacity for mitochondrial biogenesis 
(or ‘mitochondriogenesis’) as well as mitochondrial function decreases with age (Fannin, 
Lesnefsky, Slabe, Hassan, & Hoppel, 1999; Sugiyama, Takasawa, Hayakawa, & Ozawa, 
1993). Mitochondriogenesis is critical for maintaining the functional and structural integrity 
of post-mitotic tissues like skeletal muscle (Nair, 2005). Thus, age-associated decreases in 
mitochondriogenesis are responsible for many of the deleterious effects of ageing, including 
loss of muscle mass and function, i.e. sarcopenia (Lopez-Lluch, Irusta, Navas, & de Cabo, 
2008; Shah, Scariano, Waters, Qualls, Morgan, Pickett, Gasparovic, Dokladny, Moseley & 
Raj, 2009). Skeletal mitochondrial function also declines with ageing owing to decreased 
mitochondrial DNA and oxidative damage (Short, Bigelow, Kahl, Singh, Coenen-Schimke, 
Raghavakaimal & Nair, 2005). 
Mitochondrial synthesis is stimulated by the proliferator-activated receptor delta (PPARD)-
peroxisome proliferator-activated receptor γ coactivator 1α  (PPARGC1A, also termed 
PGC1-α)-nuclear respiratory factor (NRF)-mitochondrial transcription Factor A (TFAM) 
pathway. Briefly, PPARD induces promotion of PPARGC1A (Berger & Moller, 2002), which 
is the first stimulator of mitochondriogenesis. The NRF1 and 2 are intermediate transcription 
factors that stimulate the synthesis of TFAM, and the latter is the final effector activating the 
duplication of mitochondrial DNA molecules (Garesse & Vallejo, 2001; Kanki, Ohgaki, 
Gaspari, Gustafsson, Fukuoh, Sasaki, Hamasaki & Kang, 2004; Larsson, Wang, 
Wilhelmsson, Oldfors, Rustin, Lewandoski, Barsh & Clayton, 1998; Puigserver, Adelmant, 
Wu, Fan, Xu, O´Malley & Spiegelman, 1999; Puigserver & Spielgelman, 2003; Wu, 
Puigserver, Andersson, Zhang, Adelmant, Mootha, Troy, Cinti, Lowell, Scarpulla & 
Spigelman, 1999). Growing interest has focused on elucidating the factors that can affect the 
PPARD-PPARGC1A-NRF-TFAM pathway. This pathway is impaired by ageing, leading to 
increased tendency for mitochondrially-mediated apoptosis and thus eventually to sarcopenia 
(Hood, 2009). Genetic variants could also affect the PPARD-PPARGC1A-NRF-TFAM 
pathway and several important health-related phenotypes. For instance, the rs2267668 A/G 
polymorphism in PPARD and the Gly482Ser polymorphism in PPARGC1A are independently 
implicated in the modulation of aerobic fitness or insulin sensitivity (Stefan, Thamer, Staiger, 
Machicao, Machann, Schick, Venter, Niess, Laakso, Fritsche & Häring, 2007), and the 
PPARD A/G (rs2267668) polymorphism has also been associated with muscle mass in adults 
(Thamer, Machann, Stefan, Schäfer, Machicao, Staiger, Laakso, Böttcher, Claussen, Schichk, 
Fritsche & Haring, 2008). 
The main purpose of our study was to examine the influence of several genetic 
polymorphisms in the PPARD-PPARGC1A-NRF-TFAM pathway [NRF1 A/G (rs6949152), 
NRF2 A/C (rs12594956), PPARD A/G (rs2267668), PPARGC1A Gly482Ser (rs8192678), 
and TFAM Ser12Thr (rs1937)], on phenotypes indicative of muscle mass and function in a 
cohort of Caucasian (Spanish) octogenarians.  
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Methods 
Participants 
The institutional research ethics committee (Universidad Europea de Madrid, Spain) 
approved the study and it was in agreement with the ethical standards in sport and exercise 
science research (Harriss & Atkinson, 2011). After giving their written informed consent, 75 
community-dwelling healthy elderly people (21 men, 54 women; mean age: 83±5 years; 
range: 71–94 years) volunteered for this investigation. All were of the same Caucasian 
(Spanish) descent from three or more generations and were recruited from two geriatric 
nursing homes located in Spain. They received a comprehensive medical examination before 
enrolling in the study. Inclusion criteria were: age ≥70 years, able to ambulate, able to 
communicate and being capable and willing to provide consent. Exclusion criteria were: acute 
or terminal illness, myocardial infarction in the past 3 years, unstable cardiovascular disease, 
upper or lower extremity fracture in the past 3 years, severe dementia and presence of 
neuromuscular disease or drugs affecting neuromuscular function.  
Phenotype assessment 
Thigh cross sectional area. Magnetic resonance imaging (General Electric, 2421 N Mayfair 
Rd, Milwaukee, WI, USA) was used to determine the thigh muscles’ cross sectional area 
(CSA). The participants were scanned while lying supine with the knee and hip joints 
extended and their arms folded over the chest. An image located nearest to 50% of the 
femur’s length, from the lower edge of the femur to the greater trochanter, was obtained for 
the determination of the right thigh muscles’ CSA (Garatachea, Fiuza-Luces, Torres-Luque, 
Yvert, Santiago, Gómez-Gallego, Ruiz & Lucia, 2011). The 50% slice, or mid-thigh level, 
was chosen because it is commonly used to quantify thigh muscle CSA. The images were T1-
weighted (echo time 8 milliseconds; repetition time 650 milliseconds), with a 40-cm2 field of 
view and a matrix of 512x384 pixels (in-plane spatial resolution of 0.78x1.78 mm). Thigh 
CSA was normalized to body weight. 
Muscle (upper and lower body) strength. Maximal handgrip strength was measured using a 
digital dynamometer (Smedley handy dynamometer, Sportstek, Victoria, Australia), with the 
scores recorded to the nearest 0.1 kg. When performing the measurement, participants were 
instructed to maintain the standard bipedal position during the entire test with the arm at their 
side in complete extension. The dynamometer could not touch any part of the body except the 
hand being tested. Each subject performed the test with the non-dominant arm three times 
(with a 30-60 second rest period between the measurements) and the highest score was 
recorded. The grip span of the dynamometer was adjusted to the individual’s hand size (Ruiz-
Ruiz, Mesa, Gutierrez & Castillo, 2002).  
Lower body muscle fitness was assessed with the 30-second chair stand test. This test is a 
valid and reliable indicator (ICC=0.92) of lower body strength in community-dwelling old 
adults as the ones we studied here, aged ≥60 years (Jones, Rikli, & Beam, 1999; Rikli & 
Jones, 1999). Participants were asked to sit on a chair with arms crossed at the wrists and held 
against the chest. Participants completed as many ‘stand ups’ as possible within 30 seconds. 
The score was the total number of stands executed correctly within 30 seconds and 
normalized to body weight. 
Functional ability during ADLs (Barthel index). The Barthel index is an instrument widely 
used to measure the capacity of a person for the execution of ten basic activities in daily life, 
obtaining a quantitative estimation of the subject’s level of independency (Collin, Wade, 
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Davies, & Horne, 1988; Mahoney & Barthel, 1965). The ten items include: eating, 
transferring from bed to chair, using the toilet, bathing/showering, personal hygiene (e.g. 
tooth brushing, shaving) dressing, walking, stair climbing, and bowel and bladder control. 
Each individual item is scored with 0 (i.e. unable to perform without complete help or 
fecal/urine incontinence), 5 (i.e. able to perform the activity with little help or only accidental 
fecal/urine incontinence) or 10 (i.e. able to perform without any help or total fecal/urine 
continency). The sum-score ranges from 0 (totally dependent) to 100 (totally independent). In 
our study, we used the Spanish, validated version of the Barthel index (Baztán, Pérez del 
Molino, Alarcón, San Cristóbal, Izquierdo & Manzarbeitia, 1993).  
Yale Physical Activity Survey (YPAS). We recorded the participants’ levels of physical 
activity with the Yale Physical Activity Survey (YPAS). The YPAS is an interviewer-
administered questionnaire for assessing physical activity in older adults (Dipietro, 
Caspersen, Ostfeld, & Nadel, 1993). Time spent in each type of physical activity (physical 
work, exercise, and recreational activities) was multiplied by an intensity code (kcal·min-1) 
and then summed across all activities to create an index of weekly energy expenditure 
(kcal·week-1). Among physical activity questionnaires used so far, the YPAS has 
demonstrated adequate repeatability (Dipietro et al., 1993); total energy expenditure values 
obtained with this questionnaire correlate positively with accelerometer (Caltrac) activity 
units and negatively with body weight (Dipietro et al., 1993). We used the Spanish, validated 
version of the YPAS questionnaire (De Abajo, Larriba, & Marquez, 2001). 
‘Elderly muscle score’. We also computed an overall ‘elderly muscle score’ by combining the 
standardized values of the four aforementioned phenotypes (CSA, upper and lower body 
strength, Barthel index) as follows (Garatachea et al., 2011): (i) phenotype results were 
standardized for each gender by calculating the ratio of (value – mean) divided by standard 
deviation (SD); (ii) the final score was calculated as the sum of the four standardized scores.  
Muscle performance index. A ‘muscle performance index’ was calculated as follows: 30-
second stand test (number of stands)/thigh CSA (m2) (Garatachea et al., 2011). 
Genotyping 
During 2011, we extracted genomic DNA from saliva samples of the participants and 
performed genotype analyses in the genetics laboratory of the Universidad Europea de 
Madrid (Spain). Two saliva samples were obtained from each subject before the physical 
activity test. Moreover, our study followed the recommendations for replicating genotype–
phenotype association studies (Chanock et al., 2007). 
DNA purification. Genomic DNA was extracted from peripheral blood anti-coagulated with 
EDTA according to standard phenol/chloroform procedures followed by alcohol precipitation.  
Polymorphism identification. Allelic discrimination analysis was performed with predesigned 
Applied Biosystems TaqMan® SNP Genotyping Assays on demand for the five 
polymorphisms: PPARD A/G (rs2267668) (ID: C__15872729_10), PPARGC1A Gly482Ser 
(rs8192678) (ID: C___1643192_20), NRF1 A/G (rs6949152) (ID: C__29144830_10), NRF2 
A/C (rs12594956) (ID: C__32072163_20), and TFAM Ser12Thr (rs1937) (ID: 
C___8975662_10).  
PCR amplification was performed using a StepOne™ Real-Time PCR System (Applied 
Biosystems, Foster City, CA), with a denaturation stage at 95°C for 10 min, 50 cycles of 
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denaturation at 92°C for 15 sec, annealing/extension at 60°C for 1 min, and a final extension 
stage of 30 sec at 60°C.  
Data analysis 
Hardy–Weinberg equilibrium (HWE) was tested using the χ2 test. In order to analyze the 
individual effects of the five polymorphisms, we analyzed the differences in the studied 
phenotypes among genotypes of the polymorphisms by one-way analysis of covariance 
(ANCOVA), where the polymorphism was entered as a fixed factor, the phenotype was 
entered as a dependent variable, and age, sex and physical activity levels (weekly energy 
expenditure) were entered as covariates. Since the frequency of the PPARD GG genotype was 
only of n=2 and that of the NRF1 GG was only of n=1, we grouped PPARD GG and AG 
(total n=24) and NRF1 AG and AA (total n=26) respectively. All the ANCOVA tests 
(including the combined (polygenic) approach that is described below) were performed with 
men and women together, and sex and physical activity levels were included as additional 
covariates to the model. For the TFAM Ser12Thr polymorphism, all subjects carriers of the 
variant allele were women; for this reason, the sex*TFAM interaction was not performed. 
Analyses were corrected for multiple comparisons using the Bonferroni method, in which the 
threshold P-value is obtained by dividing 0.05 by the number of comparisons, i.e. n=6, 
corresponding to the 6 phenotypes we studied (thigh CSA, handgrip, 30-second chair stand, 
Barthel index, elderly muscle score and muscle performance index). Thus, threshold P-value 
was 0.008.  
On the other hand, we compared the NRF1 A/G, NRF2 A/C, PPARD A/G, PPARGC1A 
Gly482Ser, and TFAM Ser12Thr genotypes between those with low ‘elderly muscle’ scores 
(<25th sex-specific percentile) and those with high scores (≥25th sex-specific percentile) with 
the χ2 test. Finally, we used logistic regression to calculate the odds ratio for having 
‘accelerated’ sarcopenia (i.e. ‘elderly muscle score’ <25th sex-specific percentile) after 
adjusting for age, sex and physical activity levels. [The odds ratio, (OR) is the ratio of the 
odds of an event (e.g. ‘sarcopenia’) occurring in one group (e.g. individuals with one 
genotype) to the odds of it occurring in another group (e.g. individuals with another 
genotype)].  
All the analyses were performed with the PASW/SPSS Statistics 18.0 (SPSS Inc, Chicago, 
IL), and the level of significance was set at α ≤ 0.05. 
Results 
There were no failures in sample collection, DNA acquisition or genotyping procedures, 
except for PPARGC1A Gly482Ser genotyping in one participant, and NRF2 A/C genotyping 
in other participant, due in both cases to an insufficient amount of DNA gathered from saliva 
(fig. 1). Genotype frequencies were in HWE for all the polymorphisms we studied (Table 1). 
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Figure 1. Sample size description. 
Weekly energy expenditure in physical activities averaged 4,010 ± 3,952 kcal·week-1 in the 
whole cohort. 
 
Table 1. Studied polymorphisms and ‘genotypes scores’ 
Symbol	  	   Gene	   Polymorphism	   Genotypes	  
(2=’optimal’,	  
0=’worst’)	  
NRF2	   Nuclear	  respiratory	  factor-­‐2	   A/C	  (rs12594956)	   0=CC,	  1=AC,	  2=AA	  
	  
PPARD	   Peroxisome	  proliferator-­‐	  	   A/G	  (rs2267668)	  	   0=GG,	  1=AG,	  2=AA	  
activated	  receptor	  delta	  
	  
PPARGC1A	   Peroxisome	  proliferator-­‐	  	   Gly(G)482Ser(S)	  	   0=SS,	  1=GS,	  2=GG	  
activated	  receptor-­‐γ	  	   (rs8192678)	  
coactivator	  1-­‐α	  
	  
TFAM	   Transcription	  factor	  A	  	   Ser(S)12Thr(T)	  	   0=SS,	  1=ST,	  2=TT	  
mitochondrial	   (rs1937)	  
 
Therefore, The mean phenotype values across the different genotypes are shown in Table 2. 
We did not observe any interaction effect of sex*polymorphism (P>0.05) on the phenotypes. 
We found no significant differences in muscle phenotypes across genotypes (all P>0.05), 
except for a significant gen*sex interaction in thigh CSA for PPARGC1A Gly482Ser 
(P=0.030), and 30-second chair stand test for NRF2 A/C (P=0.036). Yet the two 
aforementioned P-values were above the 0.008 threshold established for correcting multiple 
comparisons with the Bonferroni method. 
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Table 2. Genotype frequencies for the different polymorphisms 
Polymorphism    HWE (P-value) 
NRF1 A/G (rs6949152) AA=49 AG=25 GG=1 0.263 
NRF2 A/C (rs12594956) AA=38 AC=28 CC=8 0.416 
PPARD A/G (rs2267668) AA=51 AG=22 GG=2 0.838 
 PPARGC1A Gly(G)482Ser(S) 
(rs8192678) 
GG=26 GS=36 SS=12 0.937 
TFAM Ser(S)12Thr(T) (rs1937) SS=66 ST=9 TT=0 0.588 
               Abbreviations: HWE, Hardy-Weinberg equilibrium. See text for gene abbreviations. 
 
We found no significant differences in genotype frequency distributions between those 
participants with a lower or higher ‘elderly muscle score’ respectively (P>0.05) (Figure 1). 
On the other hand, logistic regression analysis showed that participants with one genotype 
had no increased OR (or ‘chance’) of having accelerated sarcopenia when compared to each 
other genotype (Table 3).  
 
Figure 1. Genotype distributions of each studied genotypes by ‘elderly muscle scores’ (see text for explanations 
on score calculation). No differences existed across genotypes for the different polymorphisms. 
(NRF1 A/G: χ2 = 0.320, P = 0.852; NRF2 A/C: χ2 = 0.572, P = 0.751; PPARD A/G: χ2 = 
0.608, P = 0.738; PPARGC1A Gly482Ser: χ2 = 2.829, P = 0.243; TFAM Ser12Thr: χ2 = 0.001, 
P = 0.973).  
Test-retest reliability of our handgrip measurements was high [intra-class correlation 
coefficient (ICC) of 0.936 (95% confidence intervals (CI): 0.887-0.964; P<0.001)]. 
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Table 3: Mean ± SD estimates of muscle phenotypes by genotypes of the studied polymorphisms. 
NRF1 A/G (rs6949152) AA (n=49) AG + GG (n=26)  P 
Thigh CSA (mm2) 9,859.1 ± 2,279.4 10,557.7 ± 2,413.9  0.133 
Handgrip (kg) 22.3 ± 8.0 21.5 ± 8.8  0.333 
30-second chair stand test (Nº) 10.1 ± 4.6 9.9 ± 4.5  0.396 
Barthel index 92.4 ± 11.4 95.6 ± 7.4  0.508 
‘Elderly muscle score’ -0.7 ± 4.0 -0.4 ± 3.8  0.209 
‘Muscle performance index’ 0.1 ± 0.0 0.1 ± 0.0  0.686 
NRF2 A/C (rs12594956) AA (n=38) AC (n=28) CC (n=8) P 
Thigh CSA (mm2) 10268.8 ± 1607.3 9906.4 ± 2206.3 10225.6 ± 2589.9 0.546 
Handgrip (kg) 24.6 ± 8.1 21.0 ± 7.4 22.0 ± 8.7 0.824 
30-second chair stand test (Nº) 10.9 ± 3.6 9.5 ± 3.6 10.1 ± 5.3 0.036* 
Barthel index 92.5 ± 7.6 95.7 ± 9.0 91.8 ± 11.7 0.294 
‘Elderly muscle score’ -1.0 ± 3.9 0.0 ± 3.5 -0.9 ± 4.3 0.137 
‘Muscle performance index’ 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.053 
PPARD A/G (rs2267668) AA (n=51) GG + AG (n=24)  P 
Thigh CSA (mm2) 9,841.4 ± 2,381.4 10,687.3 ± 2,171.0  0.954 
Handgrip (kg) 20.9 ± 8.4 24.5 ± 7.5  0.140 
30-second chair stand test (Nº) 9.7 ± 4.4 10.8 ± 4.9  0.430 
Barthel index 93.8 ± 9.8 92.9 ± 11.5  0.337 
‘Elderly muscle score’ -1.0 ± 3.9 0.2 ± 3.8  0.931 
‘Muscle performance index’ 0.1 ± 0.0 0.1 ± 0.0  0.362 
PPARGC1A Gly(G)482Ser(S) 
(rs8192678) 
GG (n=26) GS (n=36) SS (n=12) 
P 
Thigh CSA (mm2) 
9,997.1 ± 2,583.2 10,039.4 ± 2,025,4 10,408.7 ± 
2,891.2 0.030* 
Handgrip (kg) 22.6 ± 8.8 20.9 ± 7.9 23.5 ± 8.4 0.870 
30-second chair stand test (Nº) 9.8 ± 4.1 9.4 ± 4.7 12.5 ± 4.9 0.300 
Barthel index 96.0 ± 8.2 91.3 ± 12.0 94.1 ± 8.0 0.363 
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‘Elderly muscle score’ -0.6 ± 3.5 -0.9 ± 4.2 -0.1 ± 3.9 0.144 
‘Muscle performance index’ 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.944 
TFAM Ser(S)12Thr(T) 
(rs1937) 
SS (n=66) ST (n=9) TT (n=0) 
P 
Thigh CSA (mm2) 10,068.6 ± 2,440.3 10,387.6 ± 1,451.6   
Handgrip (kg) 22.6 ± 8.6 18.0 ± 2.6   
30-second chair stand test (Nº) 10.4 ± 4.7 7.5 ± 2.1   
Barthel index 93.3 ± 10.4 94.4 ± 9.8   
‘Elderly muscle score’ -0.7 ± 4.1 0.1 ± 2.5   
‘Muscle performance index’ 0.1 ± 0.0 0.1 ± 0.0   
 
See text for gene abbreviations and for explanation of the ‘elderly muscle score’ and ‘muscle performance 
index’. Abbreviations: CSA, cross-sectional area. Symbol: * statistical significance was not reached after 
correction for multiple comparisons (threshold P-value=0.008). 
For the TFAM Ser(S)12Thr(T) polymorphism, all subjects carriers of the variant allele were women; for this 
reason, the sex*TFAM interaction was not performed. 
PPARD-PPARGC1A-NRF-TFAM pathway [NRF1 A/G (rs6949152), NRF2 A/C 
(rs12594956), PPARD A/G (rs2267668), PPARGC1A Gly482Ser (rs8192678), and TFAM 
Ser12Thr (rs1937)]. 
Discussion 
This is a novel study on the potential influence of mitochondriogenesis-related genes on 
muscle phenotypes in Caucasian old people, suggesting that genetic polymorphisms involved 
in the PPARD-PPARGC1A-NRF-TFAM pathway do not have a major individual or 
combined effect on such phenotypes in this population. 
Loss of mitochondriogenesis is critical in maintaining the functional and structural integrity 
of post-mitotic tissues like skeletal muscle (Fitzmaurice, 2002; Nair, 2005; Vieira & Corrente, 
2011). Thus, to identify genotypes related to mitochondriogenesis (involving the PPARD-
PPARGC1A-NRF-TFAM pathway) is of interest from a broader health perspective in aged 
people because these genotypes theoretically could be associated with muscle capacity and 
frailty in the elderly. Indeed, mitochondriogenesis is critical for the normal function of cells 
and the PPARD-PPARGC1A-NRF-TFAM pathway is impaired by chronic physical inactivity 
(Vina, Gomez-Cabrera, Borras, Froio, Sanchis-Gomar, Martinez-Bello & Pallardo, 2009a) 
and ageing (Hood, 2009). Reduced mitochondriogenesis can result in reduced muscle aerobic 
capacity (which is in itself an important health indicator), increased tendency for 
mitochondrially-mediated apoptosis, and, ultimately, accelerated sarcopenia (Hood, 2009). 
Further, research on animal models shows that impaired mitochondrial function (due to 
decreased amounts of transcription factors required for mitochondriogenesis) might be the 
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link explaining the association between low fitness levels and increased 
cardiovascular/metabolic disease risk (Wisloff, Ellingsen, Haram, Swoap, Al-Share, 
Fernström, Rezaei, Lee, Koch & Britton, 2005).  
To the best of our knowledge, no data are available in the literature concerning the association 
of genetic polymorphisms in the PPARD-PPARGC1A-NRF-TFAM pathway with muscle 
phenotypes in the elderly, despite the rationale for studying such association from a broad 
health perspective. Indeed, some genetic polymorphisms in this pathway are associated with 
important health-related phenotypes, e.g. the A/G (rs2267668) polymorphism in PPARD and 
the Gly482Ser polymorphism in PPARGC1A were independently implicated in the 
modulation of aerobic fitness and insulin sensitivity in prediabetic (or with a family history of 
type 2 diabetes) adults (Stefan et al., 2007). Previous research on adults with increased risk 
for type 2 diabetes (mean age: 47 years) has shown that carriers of the minor allele in the 
PPARD A/G (rs2267668) polymorphism had less relative leg muscle volume with their peers 
who were homozygous for the major allele (Thamer et al., 2008). Differences between our 
cohort (showing no association for the rs2267668 polymorphism) and that in the study by 
Thamer et al. (Thamer et al., 2008), particularly with respect to age, make comparisons 
difficult.  
The results of our study could be overall valid, as all the following criteria were met (Attia, 
Ioannidis, Thakkinstian, McEvoy, Scott, Minelli, Thompson, Infante-Rivard & Guyatt, 2009): 
phenotypes were accurately assessed, participants were ethnically matched, genetic 
assessment was accurate and the HWE was not violated, and we adjusted our statistical 
analyses for multiple comparisons. However, the low sample size of our cohort does 
considerably limit the ‘external validity’ (and therefore generalizability) of our results. In our 
opinion this limitation could be partly overcome by the fact that several valid muscle-related 
phenotypes were consistently and reliably assessed by the same researchers. This eliminates a 
possible	   confounder that exists in most multi-centre studies with larger samples, i.e. 
phenotype data are assessed by different investigators and analyzed together, yielding a 
considerable source of variability. The lack of data from a ‘replication’ cohort of a different 
ethnic background is also to be kept in mind.	  Thus, more research is needed using our model 
on larger groups of different ethnic backgrounds. On the other hand, we believe there are 
strengths in our design. We measured a muscle fitness test of practical applicability in the 
daily life of old people as is the 30-second chair sit-stand test (e.g. vs. less ‘applicable’ tests 
as one repetition maximum strength tests) (Gotshalk, Volek, Staron, Denegar, Hagerman & 
Kraemer, 2002) and we adjusted our analyses by a main confounder in the potential 
association between genes and muscle and exercise-related phenotypes, that is, physical 
activity levels. Finally, though there exist between-sex differences in the muscle strength and 
tendon characteristics of elderly people (Flueck, Eyeang-Békalé, Héraud, Girard, Gimpl, 
Seynnes, Rittweger, Niebauer, Mueller & Narici, 2011), the potential confounding effect of 
sex was well controlled for in our analyses.  
Western societies are ageing and thus, sarcopenia is becoming a growing health problem. To 
identify those lifestyle and genetic factors that influence muscle fitness and functional 
capacity at the end of the human lifespan, and that could be associated with more severe 
sarcopenia is of clinical and public health interest. Though they are candidates to modulate 
exercise and health-related phenotypes in younger adults, our data suggest that 
polymorphisms associated with mitochondrial biogenesis do not exert a major influence in the 
muscle phenotypes of old people.  
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